ZBH - Zimmer Biomet: Brighter Prospects In H2 2024

2024-07-01 20:46:33 ET

Summary

• Zimmer Biomet's share price has been under pressure in recent months due to soft growth, poor cash flows, and higher interest rates.
• Demographics, the rise of ASCs and technological advancements should be supportive of long-term growth.
• Zimmer Biomet also expects new product launches to accelerate growth in the second half of 2024.
• While stronger growth and improving margins should support Zimmer's stock, I continue to think that Stryker has a far stronger business.

Zimmer Biomet's ( ZBH ) share price has been under considerable pressure over the past 3 months, potentially due to a combination of soft growth, poor cash flows and higher interest rates. Some of these issues are expected to begin correcting later in the year though....

For further details see: